IL114091A - Nucleic acid sequences and expression systems for heparinase iii - Google Patents

Nucleic acid sequences and expression systems for heparinase iii

Info

Publication number
IL114091A
IL114091A IL11409195A IL11409195A IL114091A IL 114091 A IL114091 A IL 114091A IL 11409195 A IL11409195 A IL 11409195A IL 11409195 A IL11409195 A IL 11409195A IL 114091 A IL114091 A IL 114091A
Authority
IL
Israel
Prior art keywords
nucleic acid
acid sequences
expression systems
heparinase iii
iii
Prior art date
Application number
IL11409195A
Other languages
English (en)
Other versions
IL114091A0 (en
Original Assignee
Biomarin Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biomarin Pharm Inc filed Critical Biomarin Pharm Inc
Publication of IL114091A0 publication Critical patent/IL114091A0/xx
Publication of IL114091A publication Critical patent/IL114091A/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/74—Vectors or expression systems specially adapted for prokaryotic hosts other than E. coli, e.g. Lactobacillus, Micromonospora
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/88—Lyases (4.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y402/00—Carbon-oxygen lyases (4.2)
    • C12Y402/02—Carbon-oxygen lyases (4.2) acting on polysaccharides (4.2.2)
    • C12Y402/02007—Heparin lyase (4.2.2.7), i.e. heparinase I
IL11409195A 1994-06-10 1995-06-09 Nucleic acid sequences and expression systems for heparinase iii IL114091A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/258,639 US5681733A (en) 1994-06-10 1994-06-10 Nucleic acid sequences and expression systems for heparinase II and heparinase III derived from Flavobacterium heparinum

Publications (2)

Publication Number Publication Date
IL114091A0 IL114091A0 (en) 1995-10-31
IL114091A true IL114091A (en) 2005-07-25

Family

ID=22981474

Family Applications (1)

Application Number Title Priority Date Filing Date
IL11409195A IL114091A (en) 1994-06-10 1995-06-09 Nucleic acid sequences and expression systems for heparinase iii

Country Status (13)

Country Link
US (2) US5681733A (xx)
EP (2) EP0763101B1 (xx)
JP (2) JP3594608B2 (xx)
AT (2) ATE354661T1 (xx)
AU (1) AU694241B2 (xx)
CA (1) CA2192159C (xx)
DE (2) DE69532326T2 (xx)
DK (1) DK0763101T3 (xx)
ES (2) ES2213159T3 (xx)
IL (1) IL114091A (xx)
PT (1) PT763101E (xx)
WO (1) WO1995034635A1 (xx)
ZA (1) ZA954781B (xx)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6217863B1 (en) 1995-10-30 2001-04-17 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from heparinase I
US7056504B1 (en) * 1998-08-27 2006-06-06 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase I and II
WO2000012726A2 (en) * 1998-08-27 2000-03-09 Massachusetts Institute Of Technology Rationally designed heparinases derived from heparinase i and ii
EP1190364A2 (en) * 1999-04-23 2002-03-27 Massachusetts Institute Of Technology System and method for polymer notation
CA2377734A1 (en) * 1999-06-30 2001-01-11 Hamilton Civic Hospitals Research Development, Inc. Heparin compositions that inhibit clot associated coagulation factors
DE60127381D1 (de) * 2000-01-21 2007-05-03 Biomarin Pharm Inc Flavobakterium heparinum expressions-system
EP1266013B1 (en) * 2000-03-08 2014-10-15 Massachusetts Institute Of Technology Heparinase iii and uses thereof
HUP0300939A2 (hu) * 2000-09-08 2003-09-29 Hamilton Civic Hospitals Research Development, Inc. Antitrombotikus készítmények
WO2002023190A2 (en) 2000-09-12 2002-03-21 Massachusetts Institute Of Technology Methods and products related to low molecular weight heparin
CA2423469A1 (en) 2000-10-18 2002-04-25 Massachusetts Institute Of Technology Methods and products related to pulmonary delivery of polysaccharides
US6962699B2 (en) * 2002-06-03 2005-11-08 Massachusetts Institute Of Technology Rationally designed polysaccharide lyases derived from chondroitinase B
KR100804584B1 (ko) 2005-03-17 2008-02-20 재단법인서울대학교산학협력재단 글리코자미노글리칸 분해효소들의 정제방법
CN100355893C (zh) * 2005-08-18 2007-12-19 清华大学 一种表达肝素酶的方法及其专用表达载体
DK1945772T3 (en) * 2005-10-06 2016-02-22 Advanced Accelerator Applic S A Hidtil ukendt selektionssystem
US7767420B2 (en) 2005-11-03 2010-08-03 Momenta Pharmaceuticals, Inc. Heparan sulfate glycosaminoglycan lyase and uses thereof
WO2007140231A2 (en) 2006-05-25 2007-12-06 Momenta Pharmaceutical, Inc. Low molecular weight heparin composition and uses thereof
CN101723874B (zh) * 2008-10-31 2013-09-11 深圳迈瑞生物医疗电子股份有限公司 花菁类化合物及其在生物样品染色中的用途
CN101750476B (zh) * 2008-12-08 2015-06-03 深圳迈瑞生物医疗电子股份有限公司 血液分析试剂及其使用方法
CN102115456B (zh) * 2009-12-30 2014-08-20 深圳迈瑞生物医疗电子股份有限公司 花菁类化合物，包含所述化合物的组合物及其在细胞检测中的用途
CN102888391B (zh) * 2012-10-30 2015-01-21 深圳市海普瑞药业股份有限公司 肝素酶ⅱ的固定化方法
WO2018113775A1 (zh) * 2016-12-22 2018-06-28 深圳市海普瑞药业集团股份有限公司 产肝素酶的施氏假单胞菌菌株及从其衍生的肝素酶
CN114787195B (zh) * 2019-12-27 2024-01-12 深圳市天道医药有限公司 一种肝素酶iii的制备方法
CN114703168B (zh) * 2022-03-02 2023-08-18 刘颖 一种肝素酶iii

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5169772A (en) * 1988-06-06 1992-12-08 Massachusetts Institute Of Technology Large scale method for purification of high purity heparinase from flavobacterium heparinum
US5262325A (en) * 1991-04-04 1993-11-16 Ibex Technologies, Inc. Method for the enzymatic neutralization of heparin
US5714376A (en) * 1991-10-23 1998-02-03 Massachusetts Institute Of Technology Heparinase gene from flavobacterium heparinum
US5389539A (en) * 1992-11-30 1995-02-14 Massachusetts Institute Of Technology Purification of heparinase I, II, and III from Flavobacterium heparinum

Also Published As

Publication number Publication date
JPH10511841A (ja) 1998-11-17
ATE256731T1 (de) 2004-01-15
AU2771095A (en) 1996-01-05
CA2192159C (en) 2010-04-27
US5681733A (en) 1997-10-28
ES2213159T3 (es) 2004-08-16
DE69532326D1 (de) 2004-01-29
CA2192159A1 (en) 1995-12-21
DE69535400T2 (de) 2007-10-31
ZA954781B (en) 1996-02-08
AU694241B2 (en) 1998-07-16
JP3594608B2 (ja) 2004-12-02
EP0763101A1 (en) 1997-03-19
DE69532326T2 (de) 2005-02-10
ATE354661T1 (de) 2007-03-15
ES2279929T3 (es) 2007-09-01
US5919693A (en) 1999-07-06
DE69535400D1 (de) 2007-04-05
EP0763101A4 (en) 1999-09-08
DK0763101T3 (da) 2004-04-13
PT763101E (pt) 2004-05-31
IL114091A0 (en) 1995-10-31
WO1995034635A1 (en) 1995-12-21
EP1405914A1 (en) 2004-04-07
JP3588359B2 (ja) 2004-11-10
JP2004222727A (ja) 2004-08-12
EP0763101B1 (en) 2003-12-17
EP1405914B1 (en) 2007-02-21

Similar Documents

Publication Publication Date Title
IL114091A (en) Nucleic acid sequences and expression systems for heparinase iii
DE69434663D1 (de) Nukleotid-sequenzen zur kontrolle der exprimierung von dns-sequenzen in einem zellulärem wirt
HK1040401A1 (en) Isolated nucleic acid molecules which encode t cell inducible factors (tifs), the proteins encoded, and uses thereof
PL330313A1 (en) Tissue regeneration modulators
ES2145015T3 (es) Proteasas especificas de ubiquitina.
IL127477A0 (en) DNA sequences encoding phytases or ruminal microorganisms
EP1803815A3 (de) Starker homologer Promotor aus Hamster
IL140938A0 (en) Molecules designated b7l-1
NZ510356A (en) Molecules designated LDCAM
ZA859437B (en) Dna sequence encoding a hirudin-like protein and process for preparing such protein
ZA862334B (en) Process for amplifying,detecting and/or cloning nucleic acid sequences
DE69230535D1 (en) Polyphenol oxidase gene
AR015687A2 (es) Gen aislado que codifica acil transferasa
EP0759470A3 (en) Gene encoding endoglycoceramidase activator
MX9102804A (es) Nuevas secuencias de acido nucleico que codifican enzimas sintasa de acido acetohidroxi.
IL112327A (en) Dna sequence encoding an organophosphate-resistant e3 esterase, an organophosphate-resistant e3 esterase encoded thereby and uses thereof
PE20399A1 (es) Muteina ob
EP0970192A4 (en) NUCLEIC ACID ENCODING AN ALGU $ i PROTEIN (M. TUBERCULOSIS)
EP0803571A3 (en) Tab1 protein & dna coding therefor
NZ334744A (en) Method for determining expression of aberrant forms of APC protein
EP0984061A4 (en) SIALIDASES LOCALIZED ON PLASMAMEBRANES AND ENCODING DNA THEREFOR
TW342413B (en) Novel toxins isolated from Bracon Hebetor
BG105460A (en) Prv-1 gene and the use thereof
EP0911408A3 (en) DNA coding for serine/threonine kinase
IL142680A0 (en) Minimal promoters and uses thereof

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed
KB Patent renewed
MM9K Patent not in force due to non-payment of renewal fees